# Cardio3 BioSciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cardio3-biosciences

- Industry: Pharmaceuticals
- Headquarters: Belgium
- Website: www.c3bs.com
- Total disclosed funding: $9.5M
- Latest round: Series B (Jan 19, 2009)
- Investors on record: 2

## About

Cardio3 BioSciences, headquartered in Mont-Saint-Guibert (Belgium), is a biopharmaceutical company, founded in 2007, and focused on the discovery, development and commercialization of regenerative and protective therapies for cardiovascular diseases.

## Funding rounds

- Series B, Jan 19, 2009, $9.5M — Grifols, Hunza Ventures

## Investors

- Grifols — Series B
- Hunza Ventures (https://capitalatlas.ai/funds/hunza-ventures) — Series B